Key facts
- This page summarizes Karsten Voermann's Form 4 filing for GoodRx Holdings, Inc. (GDRX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 14 Mar 2024, 17:12.
Karsten Voermann - 12 Mar 2024 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- GDRX
- Reported as of
- 12 Mar 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Mar 2024, 17:12:17 UTC
- Prior SEC filing
- 08 Mar 2024
- Next SEC filing
- 10 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gracye Cheng, Attorney-in-Fact for Karsten Voermann
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Karsten Voermann filed Form 4 for GoodRx Holdings, Inc. (GDRX) on 14 Mar 2024.
Change
- Previous filing in this sequence was filed on 08 Mar 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GDRX
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 211,952
- Date
- 12 Mar 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GDRX
transaction
Derivative
Restricted Stock Unit
Award
- Transaction value
- $0
- Shares
- +357,168
- Change %
- Price
- $0.000000
- Shares after
- 357,168
- Date
- 12 Mar 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 357,168
- Exercise price
- Footnotes
- F1, F2
GDRX
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +515,793
- Change %
- Price
- $0.000000
- Shares after
- 515,793
- Date
- 12 Mar 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 515,793
- Exercise price
- $7.22
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
Footnote F2
The restricted stock unit award will vest as to 25% of the underlying shares on January 8, 2025 with the remaining 75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.
Footnote F3
The option will vest and become exercisable as to 25% of the underlying shares on January 8, 2025 with the remaining 75% underlying shares to vest in approximately equal quarterly installments thereafter for 12 quarters.